Cedric Hermans/institutroialbertdeux.be
Apr 3, 2026, 13:56
Cedric Hermans: A New Viewpoint on Rebalancing Coagulation in Haemophilia
Cedric Hermans, Head of Haemophilia Centre at the Saint-Luc University Hospital, Brussels, shared a post on LinkedIn about a recent article he and his colleagues co-authored, adding:
“Very happy to share this other viewpoint paper I co-authored with Quentin Van Thillo, Glenn Pierce and Maria Elisa Mancuso entitled ‘Balancing the benefits and risks of rebalancing coagulation in haemophilia’ and released this week in the Lancet Haematology”
Tilte: Balancing the benefits and risks of rebalancing coagulation in haemophilia
Authors: Cedric Hermans, Quentin Van Thillo, Glenn F Pierce, Maria Elisa Mancuso
Read the Full Article on The Lancet Haematology

Other posts featuring Cedric Hermans on Hemostasis Today.
-
Nov 11, 2026, 15:42Tareq Abadl: The Clinical Impact of Kell Alloimmunization
-
Nov 11, 2026, 15:30Alejandro González Veliz: Does PCI Change The Long-Term Outcome In Stable Coronary Artery Disease?
-
Nov 11, 2026, 15:25Preparing for the SoHO Regulation – EBA Board Convenes in Vienna – European Blood Alliance
-
Nov 11, 2026, 15:20Vaidehi Prasanth: IV Iron in Heart Failure – Exploring Hospitalisation Benefits vs. Infection Risk in Open Heart
-
Nov 11, 2026, 15:18Stefan Prendić: Can Algorithms Support Antibody Identification in Immunohematology?
-
Nov 11, 2026, 15:12Perioperative Challenges in Hemophilia Patients on Rebalancing Therapies
-
Nov 11, 2026, 15:03Maria Elisa Mancuso: World-Renowned Faculty and 33 Global Participants Unite at Hemophilia Academy 2026
-
Nov 11, 2026, 15:01Hassan Raza: The JAK2 V617F Revolution
-
Nov 11, 2026, 14:57Edward Lee Carter: Factor Xla Inhibition Enters Clinical Practice – FDA Approval of Asundexian